20th Annual Drug Discovery Summit

11-12th June 2019, Berlin, Germany

 

Celebrating 20 years, Oxford Global’s 20^th Annual Drug Discovery Summit will once again be coming to Berlin, Germany on the 11-12^th June 2019. Part of our R&D EU Series join over 500 attendees and benefit from key insights into overcoming the increasing challenges of drug discovery and design.

 

Featuring the following streams:

• Day 1 Stream 1: Drug Discovery Innovation and Strategies
• NEW FOR 2019! Focused Session: Protein Degradation In Drug Discovery & Drug Design
• Day 1 Stream 2: Phenotypic Screening in Drug Discovery and High Content Screening Tools
• NEW FOR 2019! Focused Session: AI and ML in Drug Discovery
• Day 2 Stream 1: Biologics and Small Molecule Drug Target Discovery for Immuno-Therapy, Autoimmune Diseases and Oncology
• Day 2 Stream 2: Innovation in Genome and Cell Based Drug Discovery, Screening, Imaging & Target Discovery

 

View the agenda: https://bit.ly/2AwW42c

 

New for 2019, the congress will be showcasing three critical focus sessions in the areas of AI/ML in drug discovery and design, improvements in hit exploration through DNA-encoded libraries and the application of protein degradation in drug discovery and development. Delegates can also expect to benefit from case studies on the use of CRISPR in drug discovery as well as presentations looking at the latest updates in modelling and organ-on-a-chip. Key therapeutic areas to be covered include oncology and immuno-oncology.

 

Featuring case studies and presentations from Chief Executive Officers, Vice Presidents and Executive/Senior Directors from leading organisations such as Bayer, Ferring Pharmaceuticals and Orbit Discovery.

 

New for 2019! The congress will be co-located with our Bispecific & Drug Development and Neuroscience Drug Development Congresses.

 

For more information contact g.alonso@oxfordglobal.co.uk or join the conversation pre-event on Twitter at @drugdiscovery1 and #RNDSeries19